0.1B, trading at HK$7.00 on the HKSE. This SniperIQ fundamentals page covers XtalPi Holdings's valuation (P/E 187.1x, P/B 2.8x), profitability (net margin 15.4%), revenue (¥782M in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.

Market CapHK
0.1B
P/E (TTM)187.1x
Net Margin15.4%
Revenue (FY25)¥782M

Full research coverage

Frequently Asked Questions

What is XtalPi Holdings's market cap?

XtalPi Holdings (2228) has a market capitalization of approximately HK

0.1B, trading at HK$7.00 on the HKSE. Market cap moves with the live share price.

What is XtalPi Holdings's P/E ratio?

XtalPi Holdings's trailing twelve-month P/E ratio is 187.1x, with a price-to-book (P/B) of 2.8x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.

How profitable is XtalPi Holdings?

XtalPi Holdings runs a net profit margin of 15.4%, a gross margin of 69.8%, and an operating margin of -54.3%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.

How much revenue does XtalPi Holdings generate?

XtalPi Holdings reported revenue of ¥782M for fiscal year 2025, with net income of ¥121M and earnings per share (EPS) of 0.0319. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.

Does XtalPi Holdings pay a dividend?

XtalPi Holdings does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.

Is XtalPi Holdings financially healthy?

XtalPi Holdings carries a debt-to-equity ratio of 0.05x and a current ratio of 14.77x, with a market beta of 1.32. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.

Is XtalPi Holdings a good stock to buy in 2026?

SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For XtalPi Holdings (2228) the key facts are: market cap HK

0.1B, P/E 187.1x, revenue ¥782M, 52-week range 5.67-15.12. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.

Track XtalPi Holdings's full fundamentals live

Get XtalPi Holdings's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.